Fengtao You
- Oncology top 5%
- Immunology top 5%
- Genetics
- Molecular Biology
- Hematology top 10%
- Co-authors
- Lin YangXiaowen TangWenhong ShenTing XuJia YinHaiping DaiGuanghua ChenDepei Wu
- Topics
- CAR-T cell therapy research (15 papers)Immune Cell Function and Interaction (7 papers)Immunotherapy and Immune Responses (3 papers)
- Cited by
- ImmunologyOncologyHematology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited KingdomPakistan
In The Last Decade
Fengtao You
16 papers receiving 644 citations
Hit Papers
Peers
Comparison fields: 5 of 39
- Oncology 575
- Immunology 473
- Genetics 134
- Molecular Biology 116
- Hematology 79
Countries citing papers authored by Fengtao You
This map shows the geographic impact of Fengtao You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengtao You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengtao You more than expected).
Fields of papers citing papers by Fengtao You
This network shows the impact of papers produced by Fengtao You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengtao You. The network helps show where Fengtao You may publish in the future.
Co-authorship network of co-authors of Fengtao You
This figure shows the co-authorship network connecting the top 25 collaborators of Fengtao You. A scholar is included among the top collaborators of Fengtao You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengtao You. Fengtao You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 14 | |
| 8 | 13 | |
| 9 | MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity. | 25 |
| 10 | 5 | |
| 11 | 2 | |
| 12 | 18 | |
| 13 | 4 | |
| 14 | 39 | |
| 15 | A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia. | 116 |
| 16 | Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.breakdown → | 356 |
| 17 | 37 |
About Fengtao You
Fengtao You is a scholar working on Oncology, Immunology and Neurology, having authored 17 papers that have together received 651 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (473 citations), Oncology (575 citations) and Hematology (79 citations). Fengtao You has collaborated with scholars based in China, United Kingdom and Pakistan. Frequent co-authors include Lin Yang, Xiaowen Tang, Wenhong Shen, Ting Xu, Jia Yin, Haiping Dai, Guanghua Chen, Depei Wu, Xiaming Zhu and Jianhua Yu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.